Accordingly, phosphorylated STAT3 expression could also be used as a guide to measure EGFR activity and identify patients that may not necessarily have EGFR mutations, but still depend on EGFR signaling for tumor cell proliferation and survival. This evidence concerns the gene EGFR and neoplasm.